Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Post by retiredcfon Aug 22, 2022 2:19pm
341 Views
Post# 34911976

Globe & Mail

Globe & Mail

10:00 AM EDT, 08/22/2022 (MT Newswires) -- Salona Global Medical Device Corporation (SGMD.V) on Monday said it has appointed a Chief Financial Officer for the company and promoted an executive as President of its subsidiary South Dakota Partners, Inc., or SDP.

Salona, which was more than 1% higher at last look, also said it has executed a national sales distribution agreement with Digitsole U.S Inc.

The company said it has named Dennis Nelson CFO of the company, effective Aug. 29. Most recently, he was Corporate Controller of Manscaped Holdings, LLC based in San Diego, California. He was previously Principal Financial Officer of Alphatec Spine, Inc., a medical technology company trading on the NASDAQ.

The company promoted Mike Plunkett to President of SDP effective Monday. He succeeds Luke Faulstick, who was appointed CEO of Salona Global on July 18. Plunkett has served as a general manager for SDP since January 2019. Prior to that, he spent 25 years in the U.S. Navy, rising to the rank of Captain.

Salona Global also said it has expanded its product line through a national distribution agreement with Digitsole, a digital health company based in France.

Under the terms of the agreement, Salona Global's subsidiary, Mio-Guard LLC, has gained the rights to distribute products from Digitsole in the U.S.

"We anticipate this Digitsole product line will drive revenue growth by expanding the products we offer to patients, athletic trainers, and physical therapists," said Salona Global's Executive Chairman Les Cross.

Price: 0.78, Change: +0.01, Percent Change: +1.30

<< Previous
Bullboard Posts
Next >>